Výsledky vyhledávání - "Daniela Štrosová"

Akademický článek

Relationship between Patient Preferences, Attitudes to Treatment, Adherence, and Quality of Life in New Users of Teriflunomide

Autor: Daniela Štrosová, Jan Tužil, Barbora Velacková Turková, Barbora Filková Pilnáčková, Lada Lžičařová de Souza, Helena Doležalová, Michaela Rašková, Michal Dufek, Tomáš Doležal

Publikováno v: Pharmaceuticals, Vol 15, Iss 10, p 1248 (2022)

Background: A poor patient adherence often limits the real-world effectiveness of an oral disease-modifying therapy (DMT) for multiple sclerosis (MS). In the present study, we aimed to map patient preferences, attitudes toward treatment, and quality

Externí odkaz: https://doaj.org/article/0e0a1255c3fd47baa8e01f53363b5cb6

Zobrazit plný text záznamu

Plný text ve formátu HTML

Direct costs in patients with nonvalvular atrial fibrillation newly indicated to apixaban: a retrospective‑prospective single‑arm cohort study

Autor: Daniela Štrosová, Jan Tužil, Barbora Pilnáčková, Lada Lžičařová, Veronika Typovská, Helena Doležalová, Martin Herold, Tomáš Doležal

Publikováno v: Vnitřní lékařství. 68:26-33

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::6d977b60b3088cf2009d82dcb581ccfd
https://doi.org/10.36290/vnl.2022.004

Zobrazit plný text záznamu

Health and economic impact of subcutaneous allergen immunotherapy in patients with pollen-induced allergic rhinoconjunctivitis: real-word evidence from the Czech Republic

Autor: Barbora Turková, Jan Tužil, Barbora Pilnáčková, Helena Doležalová, Daniela Štrosová, Vít Petrů, Ester Seberová, Tomáš Doležal

Publikováno v: Immunotherapy. 14(14)

Background: The prevalence of allergic rhinoconjunctivitis (AR) has been increasing over the years, and allergen immunotherapy (AIT) remains the only disease-modifying treatment. However, cost–effectiveness data remain scarce. Methods: In this sing

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dc5ec979e2a1e85e54a60974832f4964
https://pubmed.ncbi.nlm.nih.gov/36097687

Zobrazit plný text záznamu

Real-life experience in the effectiveness, impact on quality of life and safety of dupilumab treatment in patients with moderate to severe atopic dermatitis in the Czech Republic

Autor: Milena Tánczosová, Martina Kojanová, Monika Arenbergerová, Petr Arenberger, Tomáš Doležal, Daniela Štrosová, Jorga Fialová, Spyridon Gkalpakiotis

Publikováno v: Central European journal of public health. 30(1)

The aim of the study was to assess the effectiveness and safety of dupilumab therapy in patients with moderate-to-severe atopic dermatitis (AD) in a real-life Czech bicentric cohort.We retrospectively analysed 50 patients with moderate-to-severe AD t

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ef0764416f8e9eba4e17b6a312026246
https://pubmed.ncbi.nlm.nih.gov/35421298

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání